NRCAM variant defined by microexon skipping is a targetable cell surface proteoform in high-grade gliomas

Authors:

Abstract
No abstract available
All Related Versions
Funding Information
  • National Science Foundation Graduate Research Fellowship Program (DGE-2236662)
  • St. Baldrick's Foundation
  • ChadTough Foundation
  • National Institutes of Health (U01 CA232563)
  • National Institutes of Health (T32 HL007150)
  • National Institutes of Health (R03 CA293992)
  • National Institutes of Health (T32 CA009140)
  • National Institutes of Health (T32 CA115299)
  • National Institutes of Health (R01 HG013359)
  • National Institutes of Health (RO1 EB026892)
  • National Institutes of Health (UG3 CA290451)
  • National Institutes of Health (R03 DE033366)
  • National Science Foundation
  • CureSearch for Children's Cancer

This publication has 97 references indexed in Scilit: